Pubblicazioni
I nostri ricercatori contribuiscono al progresso della conoscenza scientifica attraverso pubblicazioni realizzate insieme ai centri e alle università con cui collaboriamo in tutto il mondo.
Internation Journal of Molecular Sciences luglio 2022
Extensive Sampling of Molecular Dynamics Simulations to Identify Reliable Protein Structures for Optimized Virtual Screening Studies: The Case of the hTRPM8 Channel
IEEE luglio 2022
EXSCALATE: An Extreme-Scale Virtual Screening Platform for Drug Discovery Targeting Polypharmacology to Fight SARS-CoV-2
Science Direct giugno 2022
Ketoprofen lysine salt has a better gastrointestinal and renal tolerability than ketoprofen acid: A comparative tolerability study in the Beagle dog
Front. Bioeng. Biotechnol. giugno 2022
Bioengineered Human Stromal Lenticule for Recombinant Human Nerve Growth Factor Release: A Potential Biocompatible Ocular Drug Delivery System
Frontiers in Pharmacology aprile 2022
Inflammation- independent antinociceptive effects of DF2755A, a CXCR1/2 selective inhibitor: a new potential therapeutic treatment for peripheral neuropathy associated to non-ulcerative interstitial cystitis/bladder pain syndrome
ACS Pharmacol. Transl. Sci. aprile 2022
Natural compounds inhibit SARS-CoV-2 nsp13 unwinding and ATPase enzyme activities
Frontiers in Pharmacology marzo 2022
Tamoxifen Twists Again: On and Off-Targets in Macrophages and Infections
International Journal of Molecular Sciences marzo 2022
MicroRNAs Expression in response to rhNGF in Epithelial Corneal Cells: Focus on Neurotrophin Signaling Pathway
Frontiers in Oncology marzo 2022
The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1low Mice
Frontiers in Pharmacology marzo 2022